If you'd invested in: Renishaw and GlaxoSmithKline

Measuring-equipment maker Renishaw has seen profits leap, but investors are sceptical about the prospects for drugmaker GSK.

If only...


Renishaw (LSE:RSW) develops and sells high-technology precision measuring and calibration equipment. Over the past 12 months, it almost doubled its market value as results continue to impress. Revenues jumped 17% to £279.5m, while adjusted pre-tax profit leapt 72% higher to £62.3m. It now expects full-year revenues to cross the £600m mark for the first time. However, the shares slipped back in January when David McMurtry the firm's founder, largest shareholder, chairman and chief executive announced he was stepping down as chief executive.

Be glad you didn't


GlaxoSmithKline (LSE:GSK) is Britain's biggest drugmaker. Last July the company said it would offload more than 130 of its non-core brands as it extended a restructuring programme meant to deliver £1bn in annual cost savings by 2020. In October, the chief executive, Emma Walmsley who took over last April announced a 4% rise in third-quarter sales to £7.8bn, helped by demand for new HIV, lung and meningitis products. Operating profit rose 31% to £1.9bn. But investors remain sceptical about the sustainability of the firm's dividend and the shares slid further.

Subscribe to MoneyWeek

Become a smarter, better informed investor with MoneyWeek.


Share tips

Share tips of the week

MoneyWeek’s comprehensive guide to the best of this week’s share tips from the rest of the UK's financial pages.
17 Jan 2020
Investment strategy

How the fear of death affects our investment processes

Many of our investment decisions are driven by one simple fact: the knowledge that, one day, we will be dead. Here, in an extract from his new book, J…
2 Jan 2020
Share tips

Share tips: eight stocks that should deliver robust returns

Ryan Ermey of US publication Kiplinger’s Personal Finance chooses his favourite stocks for the next decade, which should be able to grow for years.
28 Dec 2019
Stock markets

The good investments of the 2010s – and the bad

John Stepek takes a look back on which investments did well and which did badly in the decade that’s about to come to an end.
26 Dec 2019

Most Popular

UK Economy

How the BBC can survive the end of the TV licence

Th TV licence that funds the BBC is looking way past its sell-by date, says Matthew Lynn. Here's how it could survive without it
16 Feb 2020
UK Economy

Britain has a new chancellor – get ready for a major spending splurge

The departure of Sajid Javid as chancellor and the appointment of Rishi Sunak marks a change in the style of our politics. John Stepek explains what's…
14 Feb 2020

Living on a houseboat: the pros and cons of a floating home

Living on a houseboat sounds romantic and peaceful. But it’s not as straightforward as it looks, says Nicole Garcia Merida
14 Feb 2020

The rare earth metal that won't be a secret for long

SPONSORED CONTENT – You can’t keep a good thing hidden forever; now is the time to consider Pensana Rare Earths and the rare earth metals NdPr.
31 Jan 2020